Proposed minimum requirements for market approval of continuous glucose monitoring (CGM) systems: A viewpoint from the IFCC working group on CGMIFCC Scientific Division, Working Group on Continuous Glucose Monitoring, Milano, Italy; Department of Clinical Chemistry, Isala Clinics, Zwolle, The Netherlands.
IFCC Scientific Division, Working Group on Continuous Glucose Monitoring, Milano, Italy; Lampertheim, Germany.
IFCC Scientific Division, Working Group on Continuous Glucose Monitoring, Milano, Italy; Diabetes Research Institute of Mills-Peninsula Medical Center, San Mateo, California, USA.
IFCC Scientific Division, Working Group on Continuous Glucose Monitoring, Milano, Italy; Clinical Biochemistry Department, KAT General Hospital, Athens, Greece.
IFCC Scientific Division, Working Group on Continuous Glucose Monitoring, Milano, Italy; Vanderbilt University Medical Center, Nashville, Tennessee, USA.
IFCC Scientific Division, Working Group on Continuous Glucose Monitoring, Milano, Italy; Birmingham Women's and Children's Foundation Trust, Birmingham, UK.
IFCC Scientific Division, Working Group on Continuous Glucose Monitoring, Milano, Italy; Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
IFCC Scientific Division, Working Group on Continuous Glucose Monitoring, Milano, Italy; Department of Clinical Chemistry, Isala Clinics, Zwolle, The Netherlands.
IFCC Scientific Division, Working Group on Continuous Glucose Monitoring, Milano, Italy; Independent Scientific Consulting, Pirna, Germany.
IFCC Scientific Division, Working Group on Continuous Glucose Monitoring, Milano, Italy; Department of Pathology and Laboratory Medicine, University of California Davis Health, Sacramento, California, USA.
IFCC Scientific Division, Working Group on Continuous Glucose Monitoring, Milano, Italy; Diabetes Center Berne, Bern, Switzerland; Department of Diabetes, Endocrinology, Nutritional Medicine and Metabolism, Inselspital Bern, Bern University Hospital and University of Bern, Bern, Switzerland.
IFCC Scientific Division, Working Group on Continuous Glucose Monitoring, Milano, Italy; Institut für Diabetes-Technologie, Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm, Ulm, Germany.
Vise andre og tillknytning
2025 (engelsk)Inngår i: Diabetes, obesity and metabolism, ISSN 1462-8902, E-ISSN 1463-1326, Vol. 27, nr 7, s. 4039-4042Artikkel i tidsskrift, Letter (Annet vitenskapelig) Published
sted, utgiver, år, opplag, sider
Wiley-Blackwell Publishing Inc., 2025. Vol. 27, nr 7, s. 4039-4042
HSV kategori
Identifikatorer
URN: urn:nbn:se:oru:diva-120860DOI: 10.1111/dom.16420ISI: 001477507100001PubMedID: 40292701Scopus ID: 2-s2.0-105004364574OAI: oai:DiVA.org:oru-120860DiVA, id: diva2:1955128
2025-04-292025-04-292025-08-25bibliografisk kontrollert